|
Previous: TENET HEALTHCARE CORP, DEFA14A, 2000-08-22 |
Next: TENET HEALTHCARE CORP, DFAN14A, 2000-08-22 |
SEC 1913 (1-2000) | Persons who potentially are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
OMB APPROVAL |
OMB Number: 3235-0059 |
Expires: December 31, 2002 |
Estimated average burden hours per response. . . 13.12 |
Filed by the Registrant [ ]
Filed by a Party other than the Registrant [X]
Check the appropriate box: | |
[ ] | Preliminary Proxy Statement |
[ ] | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
[ ] | Definitive Proxy Statement |
[X] | Definitive Additional Materials |
[ ] | Soliciting Material Pursuant to §240.14a-11(c) or §240.14a-12 |
TENET HEALTHCARE CORPORATION (Name of Registrant as Specified In Its Charter) | ||
TENET SHAREHOLDER COMMITTEE, L.L.C. (Name of Person(s) Filing Proxy Statement, if other than the Registrant) | ||
Payment of Filing Fee (Check the appropriate box): | ||
[X] | No fee required. | |
[ ] | $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2) or Item 22(a)(2) of Schedule 14A. | |
[ ] | Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. | |
1) | Title of each class of securities to which transaction applies: | |
____________________________________________________________________________________
| ||
2) | Aggregate number of securities to which transaction applies: | |
____________________________________________________________________________________
| ||
3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |
___________________________________________________________________________________
|
Time for a Change
August 21, 2000
Tenet Shareholder Committee | ||||||||
Replacement Slate Nominated | ||||||||
Poor Financial Performance | ||||||||
Executive Compensation and Bloated Management | ||||||||
You Now Know: Change Is Needed |
Tenet Shareholder Committee has nominated
4 directors to replace Tenets slate of
incumbent directors
| Why? |
| Poor Financial Performance | ||
| Exorbitant Executive Compensation and Bloated Management | ||
| Poor Corporate Governance Practices |
2
Did You Know?
Tenet has the worst ROA among its competitors in fiscal 1997, 1998 (excepting HCA, due to the Medicare fraud investigation), 1999, and is on track to repeat this feat in fiscal 2000.
1995 | 1996 | 1997 | 1998 | 1999 | 2000 | |||||
2.8% | 4.3% | (2.4)% | 2.1% | 1.9% | 2.2% |
SOURCE: Form 10-K for each respective company. Dividing net income by the average of beginning and ending assets. |
3
Did You Know?
Tenet has the worst ROE among its competitors in both fiscal 1997 & 1999 and without HCAs OIG payment, THC would repeat in F2000.
1995 | 1996 | 1997 | 1998 | 1999 | 2000 | |||||
10.0% | 15.1% | (8.3)% | 7.7% | 6.7% | 7.6% |
SOURCE: Form 10-K for each respective company. Dividing net income by the average of beginning and ending equity. |
4
Did You Know?
Tenet EBITDA margins peaked in fiscal 1996 ... and have declined steadily thereafter.
1996 | 1997 | 1998 | 1999 | 2000 | ||||
19.8% | 17.5% | 18.3% | 17.1% | 17.0% |
SOURCE: Form 10-K for each respective company. Dividing EBITDA by net revenue. |
5
Did You Know?
Tenet has consistently maintained the highest leverage among its competitors. From F1995 through F2000, Tenets Debt/Equity is the highest.
1995 | 1996 | 1997 | 1998 | 1999 | 2000 | |||||
1.79x | 1.23x | 1.57x | 1.64x | 1.66x | 1.40x |
SOURCE: Form 10-K for each respective company. Dividing short-term and long-term debt by equity. |
6
Did You Know?
Since fiscal 1995, Tenet has the highest level of debt to cash flow (Debt/EBITDA) among its competitors each and every year. Close to keeping record in 2000.
1995 | 1996 | 1997 | 1998 | 1999 | 2000 | |||||
5.71x | 2.96x | 3.31x | 3.23x | 3.46x | 2.93x |
SOURCE: Form 10-K for each respective company. Dividing short-term and long-term debt by EBITDA. |
7
Did You Know?
From fiscal 1997 1999, Tenets cost of
debt capital is the highest among its
competitors.
1997 | 1998 | 1999 | 2000 | |||||||
10.05% | 8.52% | 7.90% | 7.91% |
SOURCE: Form 10-K for each respective company. Dividing interest expense by the average of beginning and ending short-term and long-term debt. |
8
Did You Know?
Since fiscal 1994, Tenet has written off more than $2.15 billion after-tax, exceeding the total equity turned over to the management team in the beginning of fiscal 1994.
Source: Form 10-K. Sum of all restructuring and asset impairment changes, tax adjusted with a 40% tax rate, plus all after-tax discontinued operations and extraordinary item charges. |
9
Did You Know?
From fiscal 1995-2000, after Capital
Expenditures, Tenet produced NO CASH.
Tenet unfortunately, has not generated any
free cash flow over the last four years...
(WST 7/3/2000).
1995 | 1996 | 1997 | 1998 | 1999 | 2000 | |||||
(8.2)% | (3.1)% | 0.0% | (1.3)% | (0.1)% | 2.2% |
SOURCE: Form 10-K for each respective company. Dividing Cash Flow From Operations less Capital Expenditures by Net Revenue. |
10
Did You Know?
| A/R Days are UP 23.6 days since F1997. This increase required $738 Million in CASH to fund, negatively impacting EPS by $0.11 annually. |
1996 | 1997 | 1998 | 1999 | 2000 | ||||
55.0 | 56.5 | 64.3 | 77.8 | 80.1 |
SOURCE: Tenets Form 10-K for each year. Change in DSO in labeled year from three years earlier. Multiply $738 million by average cost of debt capital, with 40% tax rate and 314.9 MM fully diluted shares. |
11
Did You Know?
Tenet spends over $60 million annually for its legal counsel, hiring over 700 outside law firms? (House Counsel, Code Blue, GC Healthcare, May/June 2000).
12
Did You Know?
Tenet has admitted losing $100 million per year from its physician practices, an estimated $530 million to date. Another $500 million in write-offs makes managements mistake a $1 Billion error.
Source: Tenets investor presentation admits to $100 million operating loss. Our estimate of losses since end of fiscal 1993 is $530 million. Write-offs include $157 million from F97-F99 and $177 million in first 9 months of fiscal 2000 to cover about 40% of physician contracts. Total write-off to date is $334 million. Our $500 million estimate assumes a further write-off of $166 million for remaining 60% of physician practices. |
13
Below Competitors Average Performance in F1999
| Return on Assets* | |
| Return on Capital* | |
| Return on Equity* | |
| LTD / Equity* | |
| Total Debt / Equity* | |
| Total Debt / EBITDA* | |
| EBITDA / Interest* | |
| Average Cost of Debt* | |
| EBITDA Margin | |
| EBIT Margin | |
| Interest as % revenue* | |
| Pretax Margin* | |
| EBITDA / Share Growth | |
| Cash Flow Operations / Revenue* | |
| Cash Flow Operations Capital Expenditures/ Revenue | |
| Net A/R DSO | |
| Change in A/R DSO | |
| 3 Year Change in A/R DSO | |
| Revenue / Employee | |
| EBITDA / Employee |
* Lowest in F1999
14
Did You Know?
If we give 5 points to the best performer, and 1 point to the worst performer in each of 21 financial measurements, how do they rate?
Total | ||||||||
Average | Points | |||||||
4.24 | 89 | |||||||
3.57 | 75 | |||||||
3.29 | 69 | |||||||
2.10 | 44 | |||||||
1.81 | 38 |
Tenet has the worst performance in 11 of 21 measurements. Next worst is Quorum & HMA, scoring lowest just 3 times.
Source: See Tenet Fact Book for full details of each of the 21 financial measurements. All measurements for fiscal 1999 performance. |
15
Did You Know?
| According to the LA Times, CEO Barbakow was paid $22.5 million in 1999. | |
| At $30 per share, the company has paid Barbakow nearly $74 Million in 7 years. |
Source: Tenet proxy material of cash compensation and stock options. $74 million assumes that all options are cashed in at $30 per share. CEO has not exercised any options since assuming CEO post. |
16
Did You Know?
| Ex-COO Michael Focht retired on December 31, 1999. | |
| Yet Tenet still pays him $523,992 per year for consulting for 3 years. During this 3 years, he adds 3 years to his retirement vesting schedule and will receive annual compensation in the range of $486,000-$594,000 for a period of 10 years following his retirement. |
(Source: Fiscal 1999 and Fiscal 2000 Form 10-K, Exhibit 10-N) |
17
Did You Know?
Both Tenet and HCA have 1,450 employees at their corporate / operational / regional offices. Yet HCA owns 53% more beds than Tenet. On average, THC needs 11 corporate people / hospital. HCA provides better financial results with just 7.
Source: Tenet and HCA (Columbia/HCA)s Form-10K for total employees and Tenets F1999 10-K for corporate, operational and regional employees. HCAs corporate, operational and regional employees provided by HCA. Numbers of hospitals and licensed beds according to form 10-Ks for respective companies for fiscal 1999. |
18
Did You Know?
Both THC and HCA own comparably sized hospitals (237 beds vs. 221 beds / hospital). Yet THC needs 19% more employees (968/hospital) than HCA (812/hospital) to operate the hospitals.
Source: Tenet and HCA (Columbia/HCA)s Fiscal 1999 Form-10K for total employees. Numbers of hospitals and licensed beds according to Fiscal 1999 Form 10-Ks for respective companies. |
19
Did You Know?
At the last 2 annual shareholder meetings, shareholders have overwhelmingly voted to recommend that the Board eliminate the staggered system of electing directors: 62% and 71% respectively.
Source: Tenets Form 10-Q for November quarter of each fiscal year. |
20
Did You Know?
The Board ignored shareholders twice by maintaining staggered board elections.
21
| Board ignores shareholders staggered board recommendation | |
| Management is bloated and overpaid | |
| Management after 7 years has produced the worst operating results in the industry |
22
| Senior management should be comprised of hospital operators, rather than investment bankers. | |
| Headquarters should be moved out of Santa Barbara to Nashville and support staff downsized. | |
| The corporate air force should go. |
23
| Staggered board terms should be eliminated. | |
| The company should be operated for the benefit of shareholders rather than for entrenched management. |
24
|